Icerguastat

N/A

Report date: 2024/03/04 11:57:01
NME

Base Information

Drug NameIcerguastat
Drug Alias NameSephin-1Sephin1Selective inhibitor of a holophosphatase (InFlectis BioScience)IFB-088
ClassificationSmall molecules
Mechanisms of ActionProtein phosphatase 1 regulatory subunit 15A inhibitorsGlutamate [NMDA] receptor modulators
TargetsProtein phosphatase 1 regulatory subunit 15AGlutamate [NMDA] receptor
Therapy Area/IndicationsCharcot-Marie-Tooth DiseaseAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItalyFrance
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedical Research Council
China Registration ClassN/A

Develop Information

Active CompaniesInFlectis BioScience SAS
Inactive CompaniesN/A
Active IndicationsCharcot-Marie-Tooth DiseaseAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank